Toward the future of psychiatric diagnosis: the seven pillars of RDoC

Bruce N Cuthbert, Thomas R Insel, Bruce N Cuthbert, Thomas R Insel

Abstract

Background: Current diagnostic systems for mental disorders rely upon presenting signs and symptoms, with the result that current definitions do not adequately reflect relevant neurobiological and behavioral systems--impeding not only research on etiology and pathophysiology but also the development of new treatments.

Discussion: The National Institute of Mental Health began the Research Domain Criteria (RDoC) project in 2009 to develop a research classification system for mental disorders based upon dimensions of neurobiology and observable behavior. RDoC supports research to explicate fundamental biobehavioral dimensions that cut across current heterogeneous disorder categories. We summarize the rationale, status and long-term goals of RDoC, outline challenges in developing a research classification system (such as construct validity and a suitable process for updating the framework) and discuss seven distinct differences in conception and emphasis from current psychiatric nosologies.

Summary: Future diagnostic systems cannot reflect ongoing advances in genetics, neuroscience and cognitive science until a literature organized around these disciplines is available to inform the revision efforts. The goal of the RDoC project is to provide a framework for research to transform the approach to the nosology of mental disorders.

References

    1. Wing L, Gould J, Gillberg C. Autism spectrum disorders in the DSM-V: better or worse than the DSM-IV? Res Dev Disabil. 2011;32:768–773. doi: 10.1016/j.ridd.2010.11.003.
    1. Friedman RA. Grief, depression, and the DSM-5. N Engl J Med. 2012;366:1855–1857. doi: 10.1056/NEJMp1201794.
    1. Skodol AE. Personality disorders in DSM-5. Annual Rev of Clinical Psychology. 2012;8:317–344. doi: 10.1146/annurev-clinpsy-032511-143131.
    1. Clarkin JF, Huprich SK. Do DSM-5 personality disorder proposals meet criteria for clinical utility? J Pers Disorders. 2011;25:192–205. doi: 10.1521/pedi.2011.25.2.192.
    1. Phillips J, Frances A, Cerullo MA, Chardavoyne J, Decker HS, First MB, Ghaemi N, Greenberg G, Hinderliter AC, Kinghorn WA, LoBello SG, Martin EB, Mishara AL, Paris J, Pierre JM, Pies RW, Pincus HA, Porter D, Pouncey C, Schwartz MA, Szasz T, Wakefield JC, Waterman GS, Whooley O, Zachar P. The six most essential questions in psychiatric diagnosis: a pluralogue part 1: conceptual and definitional issues in psychiatric diagnosis. Philos Ethics Humanit Med. 2012;7:3. doi: 10.1186/1747-5341-7-3.
    1. Phillips J, Frances A, Cerullo MA, Chardavoyne J, Decker H, First MD, Ghaemi N, Greenberg G, Hinderliter AC, Kinghorn WA, LoBello SG, Martin EB, Mishara AL, Paris J, Pierre JM, Pies RW, Pincus HA, Porter D, Pouncey C, Schwartz MA, Szasz T, Wakefield JC, Waterman GS, Whooley O, Zachar P. The six most essential questions in psychiatric diagnosis: a pluralogue part 3: issues of utility and alternative approaches in psychiatric diagnosis. Philos Ethics Humanit Med. 2012;7:9. doi: 10.1186/1747-5341-7-9.
    1. Varga S. Defining mental disorder: exploring the ‘natural function’ approach. Philos Ethics Humanit Med. 2011;6:1. doi: 10.1186/1747-5341-6-1.
    1. Nesse RM, Stein DJ. Towards a genuinely medical model for psychiatry. BMC Med. 2012;10:5. doi: 10.1186/1741-7015-10-5.
    1. . [ ]
    1. Sensky T, Turkington D, Kingdon D, Scott JL, Scott J, Siddle R, O’Carroll M, Barnes RE. A randomized controlled trial of cognitive-behavioral therapy for persistent symptoms in schizophrenia resistant to medication. Arch Gen Psychiatry. 2000;57:165–172. doi: 10.1001/archpsyc.57.2.165.
    1. National Heart, Lung, and Blood Institute. NHLBI Fact Book, Fiscal Year. Bethesda, MD: NHLBI; 2011. [ ]
    1. Hunger SP, Lu X, Devidas M, Camitta BM, Gaynon PS, Winick NJ, Reaman GH, Carroll WL. Improved survival for children and adolescents with acute lymphoblastic leukemia between 1990 and 2005: A report from the children’s oncology group. J Clin Oncol. 2005;2012(30):1663–1669.
    1. Kessler RC, Demler RG, Olfson FM, Pincus HA, Walters EE, Wang P, Wells KB, Zaslavsky AM. Prevalence and treatment of mental disorders, 1990 to 2003. N Engl J Med. 2005;352:2515–2523. doi: 10.1056/NEJMsa043266.
    1. Hyman SH. The diagnosis of mental disorders: the problem of reification. Ann Rev Clin Psychol. 2010;6:155–179. doi: 10.1146/annurev.clinpsy.3.022806.091532.
    1. Insel T, Cuthbert B, Garvey M, Heinssen R, Kozak M, Pine DS, Quinn K, Sanislow C, Steinberg J, Wang P. Research Domain Criteria (RDoC): toward a new classification framework for research on mental disorders. Am J Psychiat. 2010;167:748–751. doi: 10.1176/appi.ajp.2010.09091379.
    1. Clark LA, Watson D, Reynolds S. Diagnosis and classification of psychopathology: challenges to the current system and future directions. Ann Rev Psychol. 1995;46:121–153. doi: 10.1146/annurev.ps.46.020195.001005.
    1. Van Praag HM. Nosologomania: a disorder of psychiatry. World J Biol Psychiatry. 2000;1:151–158. doi: 10.3109/15622970009150584.
    1. Kendell R, Jablensky A. Distinguishing between the validity and utility of psychiatric diagnoses. Am J Psychiatry. 2003;160:4–12. doi: 10.1176/appi.ajp.160.1.4.
    1. Hyman SH. Can neuroscience be integrated into the DSM-V? Nature Rev Neurosc. 2007;8:725–732. doi: 10.1038/nrn2218.
    1. Sanislow CA, Pine DS, Quinn KJ, Garvey MA, Heinssen RK, Wang PS, Cuthbert BN. Developing constructs for psychopathology research: Research Domain Criteria. J Abn Psychol. 2010;119:631–639.
    1. Wong EHF, Yocca F, Smith MA, Lee C-M. Challenges and opportunities for drug discovery in psychiatric disorders: the drug hunters’ perspective. Int J Neuropsychopharm. 2010;13:1269–1284. doi: 10.1017/S1461145710000866.
    1. Miller G. Is pharma running out of brainy ideas? Science. 2010;329:481–482.
    1. Schizophrenia AA. The drug deadlock. Nature. 2010;468:158–159. doi: 10.1038/468158a.
    1. Mirnezami R, Nicholson J, Darzi A. Preparing for precision medicine. NEJM. 2012;366:489–491. doi: 10.1056/NEJMp1114866.
    1. Food and Drug Administration. FDA approves Kalydeco to treat rare form of cystic fibrosis. Silver Spring, MD: FDA; 2012. [ ]
    1. National Academy of Sciences. Toward Precision Medicine: Building a Knowledge Network for Biomedical Research and a New Taxonomy of Disease. Washington, DC: National Academies Press; 2011.
    1. National Institute of Mental Health. The National Institute of Mental Health Strategic Plan. Bethesda, MD: National Institute of Mental Health; 2008. [ ]
    1. Davis M. Neural systems involved in fear and anxiety measured with fear-potentiated startle. Am Psychologist. 2006;61:741–756.
    1. Treadway MT, Zald DH. Reconsidering anhedonia in depression: lessons from translational neuroscience. Neurosc Biobeh Rev. 2011;35:537–555. doi: 10.1016/j.neubiorev.2010.06.006.
    1. Wager TD, Smith EE. Neuroimaging studies of working memory: a meta-analysis. Cogn Affect Behav Neurosci. 2003;3:255–274. doi: 10.3758/CABN.3.4.255.
    1. MacCorquodale K, Meehl PE. On a distinction between hypothetical constructs and intervening variables. Psychol Rev. 1948;55:95–107.
    1. Krueger RF. The structure of common mental disorders. Arch Gen Psychiat. 1999;56:921–926. doi: 10.1001/archpsyc.56.10.921.
    1. Hudziak JJ, Achenbach TM, Althoff RR, Pine DS. A dimensional approach to developmental psychopathology. Int J Methods Psychiat Res. 2007;16:S16–S23. doi: 10.1002/mpr.217.
    1. Gold JM, Barch DM, Carter CS, Dakin S, Luck SJ, MacDonald AW III, Ragland JD, Ranganath C, Kovacs I, Silverstein SM, Strauss M, Strauss M. Clinical, functional, and intertask correlations of measures developed by the Cognitive Neuroscience Test Reliability and Clinical Applications for Schizophrenia Consortium. Schizophr Bull. 2012;38:144–152. doi: 10.1093/schbul/sbr142.
    1. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, Jones DW, Materson BJ, Oparil S, Wright JT Jr, Roccella EJ. National Heart, Lung, and Blood Institute Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure; National High Blood Pressure Education Program Coordinating Committee. The seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure. JAMA. 2003;289:2560–2571. doi: 10.1001/jama.289.19.2560.

Source: PubMed

Sponsorer og samarbejdspartnere

Medicinske tilstande

Narkotikainterventioner

3
Abonner